Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis
- PMID: 20022810
- PMCID: PMC4299826
- DOI: 10.1016/S1470-2045(09)70343-2
Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis
Abstract
Background: Analyses of microRNA expression profiles have shown that many microRNAs are expressed aberrantly and correlate with tumorigenesis, progression, and prognosis of various haematological and solid tumours. We aimed to assess the relation between microRNA expression and progression and prognosis of gastric cancer.
Methods: 353 gastric samples from two independent subsets of patients from Japan were analysed by microRNA microarray. MicroRNA expression patterns were compared between non-tumour mucosa and cancer samples, graded by diffuse and intestinal histological types and by progression-related factors (eg, depth of invasion, metastasis, and stage). Disease outcome was calculated by multivariable regression analysis to establish whether microRNAs are independent prognostic factors.
Findings: In 160 paired samples of non-tumour mucosa and cancer, 22 microRNAs were upregulated and 13 were downregulated in gastric cancer; 292 (83%) samples were distinguished correctly by this signature. The two histological subtypes of gastric cancer showed different microRNA signatures: eight microRNAs were upregulated in diffuse-type and four in intestinal-type cancer. In the progression-related signature, miR-125b, miR-199a, and miR-100 were the most important microRNAs involved. Low expression of let-7g (hazard ratio 2.6 [95% CI 1.3-4.9]) and miR-433 (2.1 [1.1-3.9]) and high expression of miR-214 (2.4 [1.2-4.5]) were associated with unfavourable outcome in overall survival independent of clinical covariates, including depth of invasion, lymph-node metastasis, and stage.
Interpretation: MicroRNAs are expressed differentially in gastric cancers, and histological subtypes are characterised by specific microRNA signatures. Unique microRNAs are associated with progression and prognosis of gastric cancer.
Funding: National Cancer Institute.
Copyright 2010 Elsevier Ltd. All rights reserved.
Conflict of interest statement
The authors declared no conflicts of interest.
Figures
Comment in
-
Using microRNAs to understand cancer biology.Lancet Oncol. 2010 Feb;11(2):106-7. doi: 10.1016/S1470-2045(09)70386-9. Epub 2009 Dec 18. Lancet Oncol. 2010. PMID: 20022811 Free PMC article. No abstract available.
Similar articles
-
Overexpression of miR-196b and HOXA10 characterize a poor-prognosis gastric cancer subtype.World J Gastroenterol. 2013 Nov 7;19(41):7078-88. doi: 10.3748/wjg.v19.i41.7078. World J Gastroenterol. 2013. PMID: 24222951 Free PMC article.
-
miRNA signature associated with outcome of gastric cancer patients following chemotherapy.BMC Med Genomics. 2011 Nov 23;4:79. doi: 10.1186/1755-8794-4-79. BMC Med Genomics. 2011. PMID: 22112324 Free PMC article.
-
Increased Expression of MicroRNA-221 in gastric cancer and its clinical significance.J Int Med Res. 2012;40(2):467-74. doi: 10.1177/147323001204000208. J Int Med Res. 2012. PMID: 22613407
-
A systematic review of microRNA expression profiling studies in human gastric cancer.Cancer Med. 2014 Aug;3(4):878-88. doi: 10.1002/cam4.246. Epub 2014 Jun 5. Cancer Med. 2014. PMID: 24902858 Free PMC article. Review.
-
A meta-analysis of the effect of microRNA-34a on the progression and prognosis of gastric cancer.Eur Rev Med Pharmacol Sci. 2018 Dec;22(23):8281-8287. doi: 10.26355/eurrev_201812_16525. Eur Rev Med Pharmacol Sci. 2018. PMID: 30556868 Review.
Cited by
-
Hotspots and trends of risk factors in gastric cancer: A visualization and bibliometric analysis.World J Gastrointest Oncol. 2024 May 15;16(5):2200-2218. doi: 10.4251/wjgo.v16.i5.2200. World J Gastrointest Oncol. 2024. PMID: 38764808 Free PMC article.
-
An overview of challenges associated with exosomal miRNA isolation toward liquid biopsy-based ovarian cancer detection.Heliyon. 2024 Apr 25;10(9):e30328. doi: 10.1016/j.heliyon.2024.e30328. eCollection 2024 May 15. Heliyon. 2024. PMID: 38707279 Free PMC article. Review.
-
Gastric Cancer in the Era of Epigenetics.Int J Mol Sci. 2024 Mar 16;25(6):3381. doi: 10.3390/ijms25063381. Int J Mol Sci. 2024. PMID: 38542354 Free PMC article. Review.
-
Simultaneous suppression of miR-21 and restoration of miR-145 in gastric cancer cells; a promising strategy for inhibition of cell proliferation and migration.Bioimpacts. 2024;14(2):27764. doi: 10.34172/bi.2023.27764. Epub 2023 Aug 27. Bioimpacts. 2024. PMID: 38505672 Free PMC article.
-
Uncovering the ceRNA Network Related to the Prognosis of Stomach Adenocarcinoma Among 898 Patient Samples.Biochem Genet. 2024 Feb 15. doi: 10.1007/s10528-023-10656-7. Online ahead of print. Biochem Genet. 2024. PMID: 38361095
References
-
- Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108. - PubMed
-
- Hohenberger P, Gretschel S. Gastric cancer. Lancet. 2003;362:305–15. - PubMed
-
- Yasui W, Yokozaki H, Fujimoto J, Naka K, Kuniyasu H, Tahara E. Genetic and epigenetic alterations in multistep carcinogenesis of the stomach. J Gastroenterol. 2000;35:111–15. - PubMed
-
- Stock M, Otto F. Gene deregulation in gastric cancer. Gene. 2005;360:1–19. - PubMed
-
- Li Q-L, Ito K, Sakakura C, et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell. 2002;109:113–24. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical